Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Ries, Rose, and Amirali Sayadipour. "Management of psychosis and agitation in medical-surgical patients who have or are at risk for prolonged QT interval." Journal of Psychiatric Practice® 20, no. 5 (2014): 338-344. |
|
Vay?so?lu, Sefa, A. Elif An?l Ya?c?o?lu, Süha Ya?c?o?lu, Sevilay Karahan, O?uzhan Karc?, ?. Can Gürel, and M. Kâz?m Yaz?c?. "Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment." Schizophrenia research 143, no. 1 (2013): 207-214. |
|
Gong, Jingbo, Ya Wang, Jianbo Liu, Xiaogao Fu, Eric FC Cheung, and Raymond CK Chan. "The interaction between positive schizotypy and high sensitivity C-reactive protein on response inhibition in female individuals." Psychiatry research 274 (2019): 365-371. |
|
Javitt, Daniel C., Migyung Lee, Joshua T. Kantrowitz, and Antigona Martinez. "Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia." Schizophrenia research 191 (2018): 51-60. |
|
Boozalis, Ted, Sridevi Devaraj, and Olaoluwa O. Okusaga. "Correlations between body mass index, plasma high-sensitivity C-reactive protein and lipids in patients with schizophrenia." Psychiatric Quarterly 90, no. 1 (2019): 101-110. |
|
de Bartolomeis, Andrea, Chiara Sarappa, Elisabetta F. Buonaguro, Federica Marmo, Anna Eramo, Carmine Tomasetti, and Felice Iasevoli. "Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis." Progress in Neuro-Psychopharmacology and Biological Psychiatry 46 (2013): 1-12. |
|
Gruber, Oliver, Antonella Santuccione Chadha, and Helmut Aach. "Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system." Frontiers in psychiatry 5 (2014): 32. |
|
Lluch, Emily, and Brian J. Miller. "Rates of hepatitis B and C in patients with schizophrenia: A meta-analysis." General hospital psychiatry 61 (2019): 41-46. |
|
Çetin, Nurdan, and Rukuye Aylaz. "The relationship of mindfulness?based psychoeducation provided to schizophrenic patients with their sociodemographic characteristics in increasing insight." Perspectives in Psychiatric Care 57, no. 1 (2021): 105-116. |
|
Salehi-Sadaghiani, Mohammad, Mehrak Javadi-Paydar, Mohammad Hadi Gharedaghi, Ali Zandieh, Pouria Heydarpour, Yashar Yousefzadeh-Fard, and Ahmad Reza Dehpour. "NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice." Psychopharmacology 223, no. 3 (2012): 345-355. |
|
New, Andrew, Veronica Theresa Tucci, and Juan Rios. "A modern-day fight Club? The stabilization and management of acutely agitated patients in the emergency department." Psychiatric Clinics 40, no. 3 (2017): 397-410. |
|
Kantrowitz, Joshua T., Michael L. Epstein, Migyung Lee, Nayla Lehrfeld, Karen A. Nolan, Constance Shope, Eva Petkova, Gail Silipo, and Daniel C. Javitt. "Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: correlation with symptoms." Schizophrenia research 191 (2018): 70-79. |
|
Calderone, Daniel J., Matthew J. Hoptman, Antígona Martínez, Sangeeta Nair-Collins, Cristina J. Mauro, Moshe Bar, Daniel C. Javitt, and Pamela D. Butler. "Contributions of low and high spatial frequency processing to impaired object recognition circuitry in schizophrenia." Cerebral cortex 23, no. 8 (2013): 1849-1858. |
|
Szabo, Katalin A., Christopher L. White, Stephen E. Cummings, Raziya S. Wang, and Cameron D. Quanbeck. "Inpatient aggression in community hospitals." CNS spectrums 20, no. 3 (2015): 223-230. |
|
Mortensen, Ninell P., and Anthony J. Hickey. "Targeting inhaled therapy beyond the lungs." Respiration 88, no. 5 (2014): 353-364. |
|
Rolland, Benjamin, Renaud Jardri, Ali Amad, Pierre Thomas, Olivier Cottencin, and Régis Bordet. "Pharmacology of hallucinations: several mechanisms for one single symptom?." BioMed Research International 2014 (2014). |
|
Solomon, Haley V., Martina Sinopoli, and Lynn E. DeLisi. "Ageing with schizophrenia: an update." Current Opinion in Psychiatry 34, no. 3 (2021): 266-274. |
|
Chan, John Gar Yan, Jennifer Wong, Qi Tony Zhou, Sharon Shui Yee Leung, and Hak-Kim Chan. "Advances in device and formulation technologies for pulmonary drug delivery." Aaps Pharmscitech 15, no. 4 (2014): 882-897. |
|
Nasrallah, H., R. Tandon, and M. Keshavan. "Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment." Epidemiology and Psychiatric Sciences 20, no. 4 (2011): 317-327. |
|
Li, Wen, Hong-He Zhang, Yu Wang, Ling Zhang, Gabor S. Ungvari, Teris Cheung, and Yu-Tao Xiang. "Poor insight in schizophrenia patients in china: A meta-analysis of observational studies." Psychiatric Quarterly (2020): 1-15. |
|